Agios Pharmaceuticals (AGIO) Stock Price Overview - Stock Analysis About AGIO Agios Pharmaceuticals, Inc , a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency
Agios Pharmaceuticals Inc (AGIO) Stock Price News - Google Get the latest Agios Pharmaceuticals Inc (AGIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions
Agios Pharmaceuticals (AGIO) Stock Price, News Analysis - MarketBeat In the past three months, Agios Pharmaceuticals insiders have sold more of their company's stock than they have bought Specifically, they have bought $0 00 in company stock and sold $194,172 00 in company stock
AGIO Stock Price Quote | Morningstar See the latest Agios Pharmaceuticals Inc stock price (AGIO:XNAS), related news, valuation, dividends and more to help you make your investing decisions